• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

READ THE DIARIES: Documents unveil Fauci’s thoughts on the lab-leak debate, mask doubts and testing failures

by July 28, 2026
written by July 28, 2026

Sen. Rand Paul, R-Ky., on Tuesday released the private diaries of Dr. Anthony Fauci, the controversial former director of the National Institute of Allergy and Infectious Diseases (NIAID) and chief government spokesperson during the COVID-19 pandemic.

The released documents show Fauci privately confronted possibilities about the virus’s origins that he publicly downplayed. On Jan. 31, 2020, he recorded that scientists considered deliberate insertion of the virus possible and agreed it required further expert review, despite later public recommendations suggesting the contrary.

He later privately questioned CDC and FDA competence, admitted officials had overstated mask ineffectiveness and repeatedly described testing and supply failures.

FAUCI’S NEWLY RELEASED COVID DIARIES REVEAL BIZARRE FIXATION ON FAME AS PANDEMIC DEATHS MOUNTED

Throughout his time as NIAID director, he made note of conversations, decisions and his thoughts about actions taken by politicians and other officials. What Paul released is Fauci’s historical record containing almost-daily entries.

“Later in the pandemic, he gloried in the positive attention he was receiving from legacy media and demonized those who questioned his official narrative — like me,” Paul said — alluding to heated exchanges during congressional hearings when Paul grilled Fauci over his pandemic response.

“Many entries in Fauci’s daily historical account completely undermine the official narrative that Fauci and other public health officials espoused,” Paul wrote in his introduction to the documents.

SLACK MESSAGES RELEASED BY RAND PAUL APPEAR TO SHOW AUTHORS OF KEY COVID-19 ORIGIN PAPER HELD PRIVATE DOUBTS

SIGN UP TO GET THE POLITICS NEWSLETTER

Paul said the “first alarm” went straight to the octogenarian immunologist, as he and two other medical experts examined the furin cleavage site in the virus and deliberated about the aforementioned genomic insertion and whether it truly escaped from a Chinese lab.

“Before most Americans knew there was an origins debate, the government’s top infectious-disease official was already confronting the lab scenario,” Paul said.

This post appeared first on https://www.foxnews.com

0 comment
0
FacebookTwitterPinterestEmail

previous post
EXCLUSIVE: Biden pardon won’t shield Fauci if he lies to Congress, Comer says
next post
J&J reaches sweeping talc deal that could end decade of litigation

related articles

Trump administration proposes stripping tax-exempt status from schools...

September 4, 2026

Blue state school district accused of defying Supreme...

September 4, 2026

Top DHS lawyer turns tables on 128 ex-judges...

September 4, 2026

Ted Cruz names ‘most powerful Democrat’ as he...

September 4, 2026

Johnson downplays GOP’s midterm woes as Democrats eye...

September 3, 2026

Collins lights up internet with response to Dem...

September 3, 2026

2028 Dem hopeful’s longtime ally exposed for deep...

September 3, 2026

GOP mail-in voting proposal could impact millions of...

September 3, 2026

Platner’s replacement faces new Senate campaign headache tied...

September 2, 2026

Trump revives Iran regime change speculation with cryptic...

September 2, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Qualcomm eyes modular AI deal as stock falls on tech selloff pressure

    June 23, 2026
  • Nikkei drops as Asian markets buckle under Fed hike shock and oil rebound

    June 23, 2026
  • FTSE slips as defence and mining stocks drag UK markets

    June 29, 2026
  • Accenture sinks 14% as lowered outlook clouds earnings beat and cybersecurity deals

    June 18, 2026
  • Why Trump picked Bill Pulte to lead US intelligence as critics question his qualifications

    June 8, 2026

Popular Posts

  • 1

    CoreWeave stock jumps 10% as analysts see major backlog upside

    June 16, 2026
  • 2

    Intel, AMD stocks slide again in aftermath of Broadcom’s weak outlook

    June 5, 2026
  • 3

    Dow tumbles 680 points as chip rout sends Nasdaq to biggest drop since 2025

    June 5, 2026
  • 4

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026
  • 5

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026

Categories

  • Editor's Pick (558)
  • Investing (1,109)
  • Stock (90)

Latest Posts

  • Vodafone share price: Technicals point to a jump to 135p as turnaround continues

    September 7, 2026
  • European markets close higher as STOXX 600 hits record, FTSE posts weekly gains

    July 3, 2026
  • Netflix stock gains as live TV, streaming bundle plans come into focus

    July 10, 2026

Recent Posts

  • Is SK Hynix stock a better pick to play AI memory market than Micron?

    July 10, 2026
  • El-Sayed’s defense of Sharia law stance sparks online eruption from Christians, conservatives: ‘He’s done’

    August 25, 2026
  • Here’s why the S&P 500 Index, SPYM, SPY, and VOO ETFs may drop 5.4% soon

    June 9, 2026

Editor’s Pick

  • Tom Lee calls chip-stock selloff a textbook buying opportunity

    June 25, 2026
  • Michael Burry shorts Micron stock, warns AI chip rally has gone too far

    July 3, 2026
  • SK Hynix stock plunges 10% after record Nasdaq debut: here’s what went wrong

    July 13, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock